Teva’s Judgment Bid Nixed In Pulmicort Case

Law360, New York (September 24, 2008, 12:00 AM EDT) -- A federal judge has rejected Teva Pharmaceutical Industries Ltd.'s summary judgment bid in AstraZeneca PLC’s suit seeking to block Teva from launching a generic version of children's asthma drug Pulmicort Respules.

On Tuesday, Judge Renee Marie Bumb of the U.S. District Court for the District of New Jersey denied Teva’s motion that it did not infringe AstraZeneca’s patents covering the drug through its attempt to gain federal approval for Pulmicort Teva. The case is likely to head to trial by January 2009, according to AstraZeneca....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.